SLC35D1 Knockout Huh-7 Cell Line
Cat.No.:
EDC08352
Species:
Human
Cell Name:
Huh-7
Gene:
SLC35D1
Gene ID:
23169
Size:
1×10⁶cells
SLC35D1 Knockout Huh-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08352 |
|---|---|
| Product Name | SLC35D1 Knockout Huh-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene ID | |
| Gene | SLC35D1 |
| Summary |
Glycosylation of cellular glycoconjugates occurs in the endoplasmic reticulum (ER) and Golgi compartment, and requires transport of nucleotide sugars from the cytosol into the lumen of the ER and Golgi by specific transporters. The protein encoded by this gene resides in the ER, and transports both UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylgalactosamine (UDP-GalNAc) from the cytoplasm to the ER lumen. It may participate in glucuronidation and/or chondroitin sulfate biosynthesis. Mutations in this gene are associated with Schneckenbecken dysplasia.[provided by RefSeq, Sep 2009]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 70% Complete medium + 20% FBS + 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC35D1 function, SLC35D1 Knockout Huh-7 Cell Line or SLC35D1 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC35D1's role as a UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter or modeling Schneckenbecken dysplasia. The Knockout line is the standard tool for asking whether SLC35D1 is required for delivering UDP-sugars to the ER and Golgi for glycosaminoglycan (GAG) synthesis — particularly chondroitin sulfate and dermatan sulfate biosynthesis. Overexpression is useful for testing transport activity or for rescue with disease-associated mutations.
For glycobiology research, the EDITGENE SLC35D1 Knockout in Huh-7 enables study of GAG biosynthesis defects in a hepatocyte-derived background — though Schneckenbecken dysplasia (caused by SLC35D1 loss-of-function mutations) is a skeletal disorder requiring chondrocyte models for physiological studies. Rescue with wild-type or transport-deficient SLC35D1 enables structure-function studies.
What are the application scenarios for this model?
Primary applications:
• Glycosaminoglycan biosynthesis: chondroitin sulfate, dermatan sulfate, and heparan sulfate analysis by enzymatic digestion + HPLC to assess SLC35D1-dependent GAG production.
• UDP-sugar Golgi transport: in vitro UDP-glucuronic acid and UDP-GalNAc transport assays using Golgi membrane preparations.
• Schneckenbecken dysplasia modeling: rescue with patient-derived SLC35D1 mutations for genotype-function studies of this skeletal disorder.
• Proteoglycan quality assessment: structural analysis of secreted proteoglycans to detect GAG chain defects.
EDITGENE recommends this model for researchers investigating UDP-sugar Golgi transport, GAG biosynthesis, and skeletal dysplasia mechanisms.
Is this SLC35D1 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes. SLC35D1 rescue experiments require attention to Golgi targeting:
• Construct design: use a codon-modified SLC35D1 sequence with a small C-terminal tag (FLAG, HA). The 10 transmembrane SLC35 family architecture must be preserved.
• Golgi localization validation: confirm Golgi/ER localization by GM130 or KDEL co-staining before functional GAG analysis.
• Disease mutation rescue: Schneckenbecken dysplasia-associated SLC35D1 mutations enable genotype-function correlation.
• Functional readout: rescue should restore chondroitin sulfate and dermatan sulfate biosynthesis assessed by enzymatic disaccharide composition analysis.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.